Clinical Trial Update: Studying Pathways of Resistance in KRAS-driven Cancers

View source ↗

Summary

A clinical trial update focused on pathways of resistance in KRAS G12C-mutant cancers; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Addario Lung Cancer Medical Institute | Conditions: KRAS P.G12C | Status: ACTIVE_NOT_RECRUITING